Body Fat and Other Metabolic Effects of Atazanavir and Efavirenz, Each Administered in Combination with Zidovudine plus Lamivudine, in Antiretroviral- Naive HIV-Infected Patients

G. Jemsek, Joseph; Arathoon, Eduardo; Arlotti, M.; Perez, C.; Sosa, N.; Pokrovskiy, Vadim; Thiry, Alexandra; Soccodato, Marine; Noor, Mustafa; Giordano, Mauro

doi:10.1086/498505

Public

Body Fat and Other Metabolic Effects of Atazanavir and Efavirenz, Each Administered in Combination with Zidovudine plus Lamivudine, in Antiretroviral- Naive HIV-Infected Patients

Published in Clinical Infectious Diseases • Dec 16, 2005

Authors:

Joseph G. Jemsek

Eduardo Arathoon

M. Arlotti

Abstract

BACKGROUND: Protease inhibitor treatment of human immunodeficiency virus (HIV)-infected individuals has been linked to the development of lipodystrophy. The effects of atazanavir on body fat distribution and related metabolic parameters were examined in antiretroviral-naive patients. METHODS: HIV-po...

Subject

Atazanavir

Efavirenz

Lamivudine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!